Clinical Trial Update: Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Rebamipide for chronic gastritis and dyspepsia has completed, assessing anti-free radical and anti-inflammatory effects and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Gastritis

Drugs mentioned

• Rebamipide (rebamipide)

Snippet

Sponsor: PT Otsuka Indonesia | Conditions: Dyspepsia, Chronic Gastritis | Phase 3 | Status: COMPLETED